FR2070162B1 - - Google Patents

Info

Publication number
FR2070162B1
FR2070162B1 FR7035209A FR7035209A FR2070162B1 FR 2070162 B1 FR2070162 B1 FR 2070162B1 FR 7035209 A FR7035209 A FR 7035209A FR 7035209 A FR7035209 A FR 7035209A FR 2070162 B1 FR2070162 B1 FR 2070162B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7035209A
Other versions
FR2070162A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9801369A external-priority patent/JPS4820559B1/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2070162A1 publication Critical patent/FR2070162A1/fr
Application granted granted Critical
Publication of FR2070162B1 publication Critical patent/FR2070162B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
FR7035209A 1969-10-25 1970-09-29 Expired FR2070162B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8541669 1969-10-25
JP9801369A JPS4820559B1 (fr) 1969-12-06 1969-12-06

Publications (2)

Publication Number Publication Date
FR2070162A1 FR2070162A1 (fr) 1971-09-10
FR2070162B1 true FR2070162B1 (fr) 1974-02-01

Family

ID=26426430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7035209A Expired FR2070162B1 (fr) 1969-10-25 1970-09-29

Country Status (5)

Country Link
BE (1) BE756914A (fr)
DE (1) DE2047973A1 (fr)
FR (1) FR2070162B1 (fr)
GB (1) GB1330704A (fr)
NL (1) NL7014367A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7196093B2 (en) 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7868011B2 (en) 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
CN101456860B (zh) * 2007-12-10 2011-02-16 中国科学院上海药物研究所 4-[9-(6-氨基嘌呤基)]-2(s)-羟基丁酸甲酯的制备方法

Also Published As

Publication number Publication date
FR2070162A1 (fr) 1971-09-10
BE756914A (fr) 1971-03-30
NL7014367A (fr) 1971-04-27
DE2047973A1 (de) 1971-05-06
GB1330704A (en) 1973-09-19

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU429630B2 (fr)
AU450150B2 (fr)
FR2070162B1 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU428131B2 (fr)
AU442322B2 (fr)
AU470661B1 (fr)
AU442554B2 (fr)
AU442357B2 (fr)
AU410358B2 (fr)
AU414607B2 (fr)
AU417208B2 (fr)
AU442285B2 (fr)
AU438128B2 (fr)
AU425297B2 (fr)
AT308690B (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AR203167Q (fr)
AU5079269A (fr)
AU5133369A (fr)
AU5228269A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse